公开(公告)号：US11739141B2

公开(公告)日：2023-08-29

申请号：US16807902

申请日：2020-03-03

Applicant: Neuracle Science Co., Ltd.

Inventor： Jae Young Seong ,  Jong Ik Hwang ,  Woong Sun ,  Eun Bee Cho ,  Won-Ki Kim

IPC: C07K16/24 ,  C12Q1/6886 ,  C07K16/18 ,  G01N33/577 ,  G01N33/68 ,  A61K39/00 ,  C07K14/47 ,  A61K38/17 ,  A61K48/00 ,  C12N15/113

CPC classification number: C07K16/24 ,  A61K38/1709 ,  A61K48/00 ,  C07K14/4701 ,  C07K14/4702 ,  C07K16/18 ,  C12N15/113 ,  C12Q1/6886 ,  G01N33/577 ,  G01N33/6896 ,  A61K2039/505 ,  C07K2317/31 ,  C07K2317/54 ,  C07K2317/55 ,  C07K2317/76 ,  C12N2310/11 ,  C12N2310/141 ,  C12Q2600/156 ,  G01N2333/47

Abstract: The present invention relates to the pharmaceutical use of FAM19A5 involved in regulating gliogenesis, and more specifically, to the use of FAM19A5 in the prevention, diagnosis, or treatment of central nervous system injuries, degenerative brain diseases, or central nervous system diseases, FAM19A5 being spread in the neural stem cells in vertebrates and regulating gliogenesis.

公开(公告)号：US20170121401A1

公开(公告)日：2017-05-04

申请号：US15404011

申请日：2017-01-11

Applicant: Neuracle Science Co., Ltd.

Inventor： Jae Young SEONG ,  Jong Ik Hwang ,  Woong Sun ,  Eun Bee Cho ,  Won-Ki Kim

IPC: C07K16/24 ,  G01N33/577 ,  G01N33/68

CPC classification number: C07K16/24 ,  A61K38/1709 ,  A61K48/00 ,  A61K2039/505 ,  C07K14/4701 ,  C07K14/4702 ,  C07K16/18 ,  C07K2317/31 ,  C07K2317/54 ,  C07K2317/55 ,  C07K2317/76 ,  C12N15/113 ,  C12N2310/11 ,  C12N2310/141 ,  C12Q1/6886 ,  C12Q2600/156 ,  G01N33/577 ,  G01N33/6896 ,  G01N2333/47

Abstract: The present invention relates to the pharmaceutical use of FAM19A5 involved in regulating gliogenesis, and more specifically, to the use of FAM19A5 in the prevention, diagnosis, or treatment of central nervous system injuries, degenerative brain diseases, or central nervous system diseases, FAM19A5 being spread in the neural stem cells in vertebrates and regulating gliogenesis.